Genome Medical

Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy

The testing program will be available for patients in the US who have symptoms or a diagnosis of cerebral palsy but no evidence of brain injury.

The company plans to use the funds to improve patient engagement and navigation within its Genome Care Delivery technology platform.

Breaking News

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.